In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.

@article{Humphries2012InVS,
  title={In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.},
  author={Romney M. Humphries and Ferric C Fang and Frank M Aarestrup and Janet A Hindler},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2012},
  volume={55 8},
  pages={1107-13}
}
Fluoroquinolone (FQ) resistance in Salmonella enterica is a significant clinical concern. Recognition of resistance by the clinical laboratory is complicated by the multiple FQ resistance mechanisms found in Salmonella. The Clinical Laboratory Standards Institute (CLSI) recently addressed this issue by revising the ciprofloxacin break points for Salmonella species. It is critical for clinicians and laboratory workers to be aware of the multiple technical issues surrounding these revised break… CONTINUE READING
20 Citations
77 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 77 references

In vivo activity of levofloxacin against Salmonella species susceptible and resistant to naladixic acid in the neutropenic murine-thigh infection model

  • WA Craig, DR Andes, D. Paterson
  • Interscience Conference on Antimicrobial Agents…
  • 2006
Highly Influential
2 Excerpts

The Diagnosis, treatment and prevention of typhoid fever

  • WHO WHO
  • Available at: http://www.who.int/vaccine_research…
  • 2012

Similar Papers

Loading similar papers…